Bringing Gene Therapies To All Eligible Patients

The pace of innovation and development is leading to an inflection point in the cell and gene therapy (C>) ecosystem. As a result, the challenges faced by the first set of biopharma companies that entered this space will be different from those that will be taking therapies to market in the near future. In this webinar, we bring a combination of voice-of-the-customer insights and ZS industry perspectives to paint a picture of what this ecosystem might look like as it evolves.

Key takeaways:

• Hear highlights from our customer research about what the C> landscape is expected to look in three to five years
• Learn the implications of this evolution on R&D, technology and commercialization
• Identify how this might affect your organization as you prepare for long-term success in the C> market